HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

I Virtanen Selected Research

I Virtanen Research Topics

Disease

5Rheumatoid Arthritis
03/2010 - 01/2000
5Neoplasms (Cancer)
08/2006 - 03/2000
4Osteoarthritis
03/2010 - 01/2000
3Wounds and Injuries (Trauma)
03/2010 - 05/2000
2Necrosis
03/2010 - 01/2003
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
09/2007 - 10/2001
2Colitis
09/2007 - 10/2001
2Arthritis (Polyarthritis)
03/2002 - 10/2001
2Carcinoma (Carcinomatosis)
06/2001 - 03/2000
1Body Weight (Weight, Body)
09/2007
1Hemorrhage
09/2007
1Foreign-Body Reaction
10/2005
1Hypoxia (Hypoxemia)
01/2004
1Neoplasm Metastasis (Metastasis)
01/2004
1Myositis (Idiopathic Inflammatory Myopathies)
01/2003
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
09/2002
1Systemic Scleroderma (Systemic Sclerosis)
09/2002
1Synovitis
03/2002
1Fibrosis (Cirrhosis)
12/2001
1Hip Osteoarthritis (Coxarthrosis)
11/2001
1Osteolysis
11/2001
1Bites and Stings (Sting)
10/2001
1Bone Resorption
10/2001
1Ankylosing Spondylitis
10/2001
1Noninfiltrating Intraductal Carcinoma (DCIS)
06/2001
1Hypertension (High Blood Pressure)
03/2001
1Carcinogenesis
12/2000
1Celiac Disease (Celiac Sprue)
07/2000
1Choriocarcinoma
06/2000
1Blister (Bulla)
05/2000
1Bullous Pemphigoid (Pemphigoid)
05/2000
1Adenoma (Adenomas)
03/2000
1Walker-Warburg Syndrome
01/2000

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
08/2006 - 01/2000
4Laminin (Merosin)IBA
03/2010 - 05/2000
3Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
09/2007 - 10/2001
3IntegrinsIBA
06/2000 - 03/2000
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2010 - 01/2003
2Interleukin-1beta (Interleukin 1 beta)IBA
03/2010 - 01/2003
2Messenger RNA (mRNA)IBA
03/2010 - 06/2001
2laminin alpha5IBA
03/2010 - 05/2000
2Collagen Type IV (Type IV Collagen)IBA
12/2007 - 06/2001
2montelukast (Singulair)FDA Link
09/2007 - 10/2001
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
09/2007 - 10/2001
2LeukotrienesIBA
09/2007 - 10/2001
2SodiumIBA
09/2007 - 03/2001
2ProstaglandinsIBA
09/2007 - 10/2001
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2004 - 09/2002
2AntigensIBA
03/2002 - 05/2000
2AcidsIBA
10/2001 - 10/2001
2LigandsIBA
07/2001 - 03/2000
2Protein Isoforms (Isoforms)IBA
07/2000 - 03/2000
2TenascinIBA
07/2000 - 05/2000
2KalininIBA
05/2000 - 03/2000
2Collagen Type VIIIBA
05/2000 - 03/2000
1Drinking WaterIBA
09/2007
12,5-dichloro-4-bromophenol (B 2)IBA
09/2007
1Dextrans (Dextran)FDA Link
09/2007
1ThromboxanesIBA
09/2007
1Leukotriene B4IBA
09/2007
1Cyclooxygenase 1IBA
09/2007
1Capsules (Microcapsules)IBA
10/2005
1Extracellular Matrix ProteinsIBA
01/2004
1CytokinesIBA
01/2004
1Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA
01/2003
1Biotin (Vitamin H)FDA Link
12/2001
1AvidinIBA
12/2001
1Monoclonal AntibodiesIBA
12/2001
1PAceinIBA
12/2001
1VitronectinIBA
12/2001
1Peptides (Polypeptides)IBA
11/2001
1Coloring Agents (Dyes)IBA
11/2001
1Parathyroid Hormone-Related ProteinIBA
11/2001
1cysteinyl-leukotrieneIBA
10/2001
1EicosanoidsIBA
10/2001
1Peroxidase (Myeloperoxidase)IBA
10/2001
1zileuton (Zyflo)FDA Link
10/2001
1Lipoxygenase InhibitorsIBA
10/2001
1Cathepsin KIBA
10/2001
1HLA-D AntigensIBA
10/2001
1AutoantigensIBA
10/2001
1Lymphotoxin-alpha (Lymphotoxin)IBA
10/2001
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
07/2001
1Cyclosporine (Ciclosporin)FDA LinkGeneric
03/2001
1IsoenzymesIBA
12/2000
1Membrane Proteins (Integral Membrane Proteins)IBA
12/2000
1Carbonic Anhydrases (Carbonic Anhydrase)IBA
12/2000
1Fibronectins (Fibronectin)IBA
07/2000
1Integrin beta4IBA
05/2000
1PlectinIBA
05/2000
1DystoninIBA
05/2000
1Keratins (Keratin)IBA
05/2000
1calcipotriene (calcipotriol)FDA LinkGeneric
05/2000
1Integrin alpha3beta1IBA
03/2000
1Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
02/2000
1tenascin XIBA
01/2000

Therapy/Procedure

5Hip Replacement Arthroplasty (Total Hip Replacement)
03/2010 - 01/2000
1Reoperation
10/2001
1Prostheses and Implants (Prosthesis)
10/2001
1Electrodes (Electrode)
10/2001